The U.S. Federal Trade Commission (FTC) has temporarily halted its opposition to Amgen’s $27.8 billion acquisition of Horizon Therapeutics, according to a filing on Friday. The suspension will allow the…
US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics
By News Team August 26, 2023